Furthermore, the two present RSEAC patients showed high frequencies of infiltrating T cell (CD8) expression and high PD-1 expression in infiltrating T cells in the tumor, suggesting that immune checkpoint inhibitors are useful for treating these types of cancers. The gene discussed is CD8A; the disease is cancer.